AdipoGen Life Sciences PANoptosis research antibodies

Programmed cell death plays a crucial role in development and host defence with an overlap and crosstalk between pyroptosis, apoptosis and necroptosis in the same cell population, leading to the concept of total cell death called PANoptosis. During PANoptosis activated by bacterial and viral triggers, inflammatory cell death occurs through the collective activation of pyroptosis, apoptosis and necroptosis, which can circumvent pathogen-mediated inhibition of individual death pathways.

AdipoGen Life Sciences provides thoroughly validated and published antibodies for PANoptosis, apoptosis, pyroptosis and necroptosis research. The company’s collection includes PANoptosome Human or Mouse Antibody Starter Sets, as well as individual antibodies that recognise Caspase-1, -4, -8, FLIP, FADD and NLRP3/NALP3 proteins.

The antibodies are distributed in Australia and New Zealand by Sapphire Bioscience.